A Monotonous Population of Elongated Cells (MPECs) in Colorectal Adenoma Indicates a High Risk of Metachronous Cancer

Accurate predictors for metachronous colorectal cancer (CRC) development after polypectomy are lacking. We evaluated the prognostic value of classical clinicopathologic features and a monotonous population of elongated cells (MPECs) in colorectal adenomas from 171 consecutively selected population-based patients with long-term follow-up. Quantitative image analysis, and univariate and multivariate regression analysis were applied. Ten of 171 adenomas (5.8%) developed metachronous CRC (defined as >24 mo interval and >5 cm from the index adenoma to the cancer). Median follow-up of adenomas with metachronous CRC was 68.4 and without cancer 149.7 months (range: 25 to 192 and 25 to 256, respectively). The most prognostic classical features were the localization of the marker adenoma as proximal (ie, in the cecum through transverse colon) versus distal from the transverse colon [P=0.0003, hazard ratio (HR)=8] and the number of polyps found during colonoscopy (≤2 vs.>2, P=0.002, HR=6). Quantitative features of the MPECs included the longest nuclear axis and variance of the number of nuclei with 2 neighbors (higher and lower in cancer cases, respectively). Of the 171 adenomas, 50 (29%) had MPECs, of which 9 (18%) patients developed metachronous CRC at follow-up, contrasting 1/121 (0.8%) without MPECs (P=0.0003, HR=23). MPECs occurred in both low-grade and high-grade dysplasia, and in tubular and (tubulo) villous adenomas. MPECs had the strongest predictive value for metachronous CRC development. Adenomas proximally located had additional value but only if they were MPEC positive (which only occurred in 5 adenomas, 3 of which (60%) developed cancer). Having more than 2 polyps also had additional prognostic value but only in MPEC-negative adenomas [10 cases; 1 (10%) developed cancer]. Dysplasia grade and histologic growth pattern had no additional value. Thus, colorectal adenomas with subsequent metachronous cancer development can be identified more accurately with MPECs than with classical prognostic factors.

[1]  T. Eide,et al.  Dysplasia in colorectal adenomas related to the presence of O-acylated sialic mucin and to morphometric measurements. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology.

[2]  H. Körner,et al.  Microsatellite instability in colorectal cancer , 2006, The British journal of surgery.

[3]  I. Shih,et al.  Nuclear size distinguishes low- from high-grade ovarian serous carcinoma and predicts outcome. , 2005, Human pathology.

[4]  Carol R Regueiro,et al.  AGA Future Trends Committee report: Colorectal cancer: a qualitative review of emerging screening and diagnostic technologies. , 2005, Gastroenterology.

[5]  C. McArdle,et al.  Improvement in survival following surgery for colorectal cancer , 2005, The British journal of surgery.

[6]  T. Byers,et al.  Colorectal cancer in patients under close colonoscopic surveillance. , 2005, Gastroenterology.

[7]  P. V. van Diest,et al.  The molecular genetics and morphometry‐based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system , 2005, Cancer.

[8]  J. Baak,et al.  Genomics and proteomics--the way forward. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  Hans Clevers,et al.  Self-Renewal and Cancer of the Gut: Two Sides of a Coin , 2005, Science.

[10]  H. Körner,et al.  Systematic follow-up after curative surgery for colorectal cancer in Norway: A population-based audit of effectiveness, costs, and compliance , 2005, Journal of Gastrointestinal Surgery.

[11]  Shung-Haur Yang,et al.  Metachronous colorectal cancer: necessity of post-operative colonoscopic surveillance , 2005, International Journal of Colorectal Disease.

[12]  P. Morel,et al.  Proximal Location of Colon Cancer Is a Risk Factor for Development of Metachronous Colorectal Cancer: A Population-Based Study , 2005, Diseases of the colon and rectum.

[13]  M. Pignone.  Screening for colorectal cancer: good, but not perfect. , 2004, Gastroenterology.

[14]  J. Selby,et al.  The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. , 2004, Gastroenterology.

[15]  J. Habbema,et al.  Colorectal cancer risk in adenoma patients: A nation‐wide study , 2004, International journal of cancer.

[16]  G. Gaudernack,et al.  Resolving the evolutionary paradox of genetic instability: a cost–benefit analysis of DNA repair in changing environments , 2004, FEBS letters.

[17]  J. Baak,et al.  Quantitative Molecular Parameters to Identify Low-Risk and High-Risk Early CIN Lesions: Role of Markers of Proliferative Activity and Differentiation and Rb Availability , 2004, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[18]  E. Kuipers,et al.  Quantitative Assessment of Gastric Antrum Atrophy Shows Restitution to Normal Histology after Helicobacter pylori Eradication , 2004, Digestion.

[19]  M. Coleman,et al.  Colorectal cancer survival trends in Norway 1958-1997. , 2004, European journal of cancer.

[20]  M. Droller.  Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial cell carcinomas of the urinary bladder. , 2003, Journal of Urology.

[21]  J. V. van Sandick,et al.  The Role of Quantitative Pathology in Clinical Decision Making for Barrett’s Oesophagus , 2003, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[22]  M. Bretthauer,et al.  Inter‐endoscopist variation in polyp and neoplasia pick‐up rates in flexible sigmoidoscopy screening for colorectal cancer , 2003, Scandinavian journal of gastroenterology.

[23]  J. Gregor,et al.  Screening for colorectal cancer: the cost to find an advanced adenoma , 2002, American Journal of Gastroenterology.

[24]  J. Baak,et al.  The framework of pathology: good laboratory practice by quantitative and molecular methods , 2002, The Journal of pathology.

[25]  J. Arends,et al.  Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. , 2002, Gastroenterology.

[26]  H. Moriwaki,et al.  Metachronous colon tumors: risk factors and rationale for the surveillance colonoscopy after initial polypectomy , 2002, Journal of Cancer Research and Clinical Oncology.

[27]  B. Leggett,et al.  Emerging concepts in colorectal neoplasia. , 2002, Gastroenterology.

[28]  D. Alberts,et al.  Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics. , 2001, Gastroenterology.

[29]  J. Scholefield,et al.  Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial , 2001, Gut.

[30]  S. J. Mills,et al.  Colonic crypt cell proliferation state assessed by whole crypt microdissection in sporadic neoplasia and familial adenomatous polyposis , 2001, Gut.

[31]  L. Aaltonen,et al.  Pathology and genetics of tumours of the digestive system , 2000 .

[32]  R. Scheiden,et al.  Colorectal high-grade adenomas: incidence, localization and adenoma-adenocarcinoma ratio in a retrospective and comparative population-based study of 225 consecutive cases between 1988 and 1996 , 2000, International Journal of Colorectal Disease.

[33]  DeSilva Wm.  Developing a molecular marker for metachronous colorectal cancer. , 1999 .

[34]  K. Endo,et al.  Computerized nuclear morphometry is a useful technique for evaluating the high metastatic potential of colorectal adenocarcinoma , 1999, Cancer.

[35]  Junji Kato,et al.  Aberrant crypt foci of the colon as precursors of adenoma and cancer , 1998, The New England journal of medicine.

[36]  G. Meijer,et al.  Predicting the risk of metachronous colorectal cancer in patients with rectosigmoid adenomas using quantitative pathological features. A case–control study , 1998, The Journal of pathology.

[37]  D. Ahnen,et al.  Effects of epidermal growth factor and dimethylhydrazine on crypt size, cell proliferation, and crypt fission in the rat colon. Cell proliferation and crypt fission are controlled independently. , 1997, The American journal of pathology.

[38]  A. Neugut,et al.  Prevalence and incidence of colorectal adenomas and cancer in asymptomatic persons. , 1997, Gastrointestinal endoscopy clinics of North America.

[39]  S. Finkelstein,et al.  K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients. , 1997, Cancer letters.

[40]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[41]  D. Ransohoff,et al.  Metachronous colon cancer in persons who have had a large adenomatous polyp. , 1996, The American journal of gastroenterology.

[42]  J. Goldblum,et al.  Management and outcome of patients with invasive carcinoma arising in colorectal polyps. , 1995, Gastroenterology.

[43]  B. Ruebner,et al.  Colorectal cancer and noncancer patients have similar labeling indices by microscopy and computed image analysis. , 1995, Human pathology.

[44]  D. Rex,et al.  Colonoscopy: a review of its yield for cancers and adenomas by indication. , 1995, The American journal of gastroenterology.

[45]  G. Meijer,et al.  Stereological assessment of architectural changes in dysplastic epithelium of colorectal adenomas. , 1994, Pathology, research and practice.

[46]  I. Köves,et al.  Correlation between colon adenoma and cancer. , 1993, European Journal of Surgical Oncology.

[47]  M. Sporn,et al.  TGF-beta expression in the human colon: differential immunostaining along crypt epithelium. , 1993, British Journal of Cancer.

[48]  J. Hardcastle,et al.  Individuals with a strong family history of colorectal cancer demonstrate abnormal rectal mucosal proliferation , 1993, The British journal of surgery.

[49]  P. V. van Diest,et al.  Syntactic structure analysis of the arrangement of nuclei in dysplastic epithelium of colorectal adenomatous polyps. , 1992, Analytical and quantitative cytology and histology.

[50]  J Cuzick,et al.  Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. , 1992, The New England journal of medicine.

[51]  M. Wargovich,et al.  A follow-up study of colonic epithelial proliferation as a biomarker ina Native-American family with hereditary nonpolyposis colon cancer. , 1991, Journal of the National Cancer Institute.

[52]  A. Zauber,et al.  The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. , 1990, Gastroenterology.

[53]  A. Zauber,et al.  The National Polyp Study , 1990 .

[54]  J. Baak,et al.  The influence of fixatives and other variations in tissue processing on nuclear morphometric features. , 1989, Analytical and quantitative cytology and histology.

[55]  L. Loeb,et al.  Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[56]  A. Smeulders,et al.  Analysis of measuring system parameters that influence reproducibility of morphometric assessments with a graphic tablet. , 1988, Human pathology.

[57]  T. Eide.  A morphometrical analysis of dysplasia in small adenomas of the large instestine , 1987, Virchows Archiv A.

[58]  O. Terpstra,et al.  Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. , 1987, Gastroenterology.

[59]  T. Eide.  Risk of colorectal cancer in adenoma‐bearing individuals within a defined population , 1986, International journal of cancer.

[60]  L. Melton,et al.  Colorectal polyps and the risk of subsequent carcinoma. , 1986, Mayo Clinic proceedings.

[61]  L. Melton,et al.  Treatment of small colorectal polyps: a population-based study of the risk of subsequent carcinoma. , 1984, Mayo Clinic proceedings.

[62]  M. Lipkin,et al.  Proliferative patterns in colonic mucosa in familial polyposis , 1975, Cancer.

[63]  D. Jäger,et al.  [Systemic therapy for colorectal cancer]. , 2005, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

[64]  A. Iwashita,et al.  The role of adenoma for colorectal cancer development: differences in the distribution of adenoma with low-grade dysplasia, high-grade dysplasia, and cancer that invades the submucosa. , 2002, Surgery.

[65]  Hans Clevers,et al.  The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. , 2002, Cell.

[66]  J. Jass,et al.  Tumours of the colon and rectum: Hyperplastic polyposis , 2000 .

[67]  W. M. D. de Silva.  Developing a molecular marker for metachronous colorectal cancer. , 1999, Ceylon Medical Journal.

[68]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.